Display options
Cite
Piskunowicz M, Kosiak W, Batko T, et al. Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison. J Ultrason. 2013;13(55):438-45doi: 10.15557/JoU.2013.0047.
Piskunowicz, M., Kosiak, W., Batko, T., Adamkiewicz-Drożyńska, E., & Szarmach, A. (2013). Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison. Journal of ultrasonography, 13(55), 438-45. https://doi.org/10.15557/JoU.2013.0047
Piskunowicz, Maciej, et al. "Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison." Journal of ultrasonography vol. 13,55 (2013): 438-45. doi: https://doi.org/10.15557/JoU.2013.0047
Piskunowicz M, Kosiak W, Batko T, Adamkiewicz-Drożyńska E, Szarmach A. Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison. J Ultrason. 2013 Dec;13(55):438-45. doi: 10.15557/JoU.2013.0047. Epub 2013 Dec 30. PMID: 26675552; PMCID: PMC4579670.
Copy Download .nbib Format: NLM
Share it on

J Ultrason. 2013 Dec;13(55):438-45. doi: 10.15557/JoU.2013.0047. Epub 2013 Dec 30.

Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison.

Journal of ultrasonography

Maciej Piskunowicz, Wojciech Kosiak, Tomasz Batko, Elżbieta Adamkiewicz-Drożyńska, Arkadiusz Szarmach

Affiliations

  1. Zak?ad Radiologii, Gda?ski Uniwersytet Medyczny, Gda?sk, Polska.
  2. Klinika Pediatrii, Hematologii, Onkologii i Endokrynologii Dzieci?cej, Gda?ski Uniwersytet Medyczny, Gda?sk, Polska.

PMID: 26675552 PMCID: PMC4579670 DOI: 10.15557/JoU.2013.0047

Abstract

The lack of registration of ultrasound contrast agents for use in patients below the age of 18 is a significant limitation of their usage. Despite this, examinations with the use of contrast agents are conducted in numerous centers, mainly as part of the diagnostic process of vesicoureteral reflux. Examinations after an intravenous administration of contrast agents are conducted rarely. The reason for this is not only the lack of registration, but also the lack of studies on their safety profile in paediatric patients or no guidelines concerning the dosage. It seems that imaging with the use of such agents could help solve certain clinical problems when other diagnostic methods fail. The paper presents selected cases of pediatric patients treated in oncological departments, in whom the examination with the use of ultrasound contrast agents had a considerable influence on the diagnostic and therapeutic process.

Keywords: CEUS; contrast agents; oncology; pediatric patients; ultrasound

References

  1. Klin Padiatr. 2009 Sep;221(5):312-7 - PubMed
  2. J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 - PubMed
  3. Pediatr Radiol. 2011 Nov;41(11):1486-8 - PubMed
  4. Ultraschall Med. 2011 Feb;32(1):83-6 - PubMed
  5. Ultraschall Med. 2010 Oct;31(5):492-9 - PubMed
  6. Pediatr Blood Cancer. 2006 Feb;46(2):127-34 - PubMed
  7. Eur J Cancer. 2009 Jan;45(2):228-47 - PubMed
  8. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):179-84 - PubMed
  9. Ultraschall Med. 2009 Aug;30(4):376-82 - PubMed
  10. Eur J Pediatr. 2005 Sep;164(9):552-8 - PubMed
  11. Br J Radiol. 2003 Jul;76(907):433-6 - PubMed

Publication Types